Search in:

Fatigue: Biomedicine, Health & Behavior Volume 7, 2019 - Issue 4

Submit an article Journal homepage

Open access

30,660

Views

CrossRef citations to date

Altmetric

Research Articles

Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Olli Poloa Unesta Sleep and Breathing Center, Tampere, FinlandCorrespondence[email protected]
View further author information

Pia Pesonena Unesta Sleep and Breathing Center, Tampere, FinlandView further author information

Essi Tuominena Unesta Sleep and Breathing Center, Tampere, Finland;b Department of Respiratory Medicine, University of Tampere, Tampere, FinlandView further author information

Pages 207-217 | Received 13 Sep 2019, Accepted 11 Nov 2019, Published online: 19 Nov 2019

Cite this article
https://doi.org/10.1080/21641846.2019.1692770
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (10)

Leonard A. Jason, Benjamin H. Natelson, Hector Bonilla, Zaki A. Sherif, Suzanne D. Vernon, Monica Verduzco Gutierrez, Lisa O’Brien & Emily Taylor. (2023) What Long COVID investigators can learn from four decades of ME/CFS research. Brain Behavior and Immunity Integrative 4, pages 100022.
Crossref

Hector Bonilla, Lu Tian, Vincent C. Marconi, Robert Shafer, Grace A. McComsey, Mitchel Miglis, Philip Yang, Andres Bonilla, Lauren Eggert & Linda N. Geng. (2023) Low-dose naltrexone use for the management of post-acute sequelae of COVID-19. International Immunopharmacology 124, pages 110966.
Crossref

Jamie T Carreno-Davidson, Colleen M Castellani, Joseph J Carreno, Jesse P DeLuca, Daniel J Selig, Chau V Vuong, Stefan M Pasiakos & Bradley M Ritland. (2023) Daily Naltrexone Use Does Not Adversely Affect Physical, Cognitive or Marksmanship Performance in U.S. Army Soldiers. Military Medicine.
Crossref

Salomon Poliwoda, Bryant Noss, Gia Thinh D. Truong, Zachary A. Creech, Sarang S. Koushik, Ivan Urits & Omar Viswanath. (2023) The Utilization of Low Dose Naltrexone for Chronic Pain. CNS Drugs 37:8, pages 663-670.
Crossref

Carmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, Kirsten Wittke, Elisa Stein, Christiana Franke, Harald Prüss, Hannah Preßler, Marie-Luise Machule, Heinrich Audebert, Carsten Finke, Hanna Gwendolyn Zimmermann, Birgit Sawitzki, Christian Meisel, Markus Toelle, Anne Krueger, Anna C. Aschenbrenner, Joachim L. Schultze, Marc D. Beyer, Markus Ralser, Michael Mülleder, Leif Erik Sander, Frank Konietschke, Friedemann Paul, Silvia Stojanov, Lisa Bruckert, Dennis M. Hedderich, Franziska Knolle, Gabriela Riemekasten, Maria J. G. T. Vehreschild, Oliver A. Cornely, Uta Behrends & Susen Burock. (2023) Fighting Post-COVID and ME/CFS – development of curative therapies. Frontiers in Medicine 10.
Crossref

Lindsay S. Petracek, Camille A. Broussard, Renee L. Swope & Peter C. Rowe. (2023) A Case Study of Successful Application of the Principles of ME/CFS Care to an Individual with Long COVID. Healthcare 11:6, pages 865.
Crossref

Warren P. Tate, Max O. M. Walker, Katie Peppercorn, Anna L. H. Blair & Christina D. Edgar. (2023) Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID. International Journal of Molecular Sciences 24:6, pages 5124.
Crossref

Natalie Eaton-Fitch, Stanley Du Preez, Hélène Cabanas, Katsuhiko Muraki, Donald Staines & Sonya Marshall-Gradisnik. (2022) Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients. Journal of Translational Medicine 20:1.
Crossref

Stanley Du Preez, Helene Cabanas, Donald Staines & Sonya Marshall-Gradisnik. (2021) Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review. International Journal of Environmental Research and Public Health 18:20, pages 10708.
Crossref

Helene Cabanas, Katsuhiko Muraki, Natalie Eaton-Fitch, Donald Ross Staines & Sonya Marshall-Gradisnik. (2021) Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment. Frontiers in Immunology 12.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date